Skip to main content
. 2025 Dec 18;13:e20528. doi: 10.7717/peerj.20528

Table 1. Comparison of HFC and other biomarkers between the malignant and benign effusion groups.

Biomarkers Malignant effusion group Benign effusion group P value
HFC# (/μL) 42 (16, 149) 13 (4, 38) <0.001
HFC% (/100WBC) 6.4 (2.3, 15.8) 1.5 (0.4, 5.5) <0.001
TC (106/L) 950 (440, 2,081) 832 (235, 2,733) 0.354
WBC (106/L) 842 (390, 1,814) 807 (231, 2,711) 0.954
RBC (106/L) 4,000 (1,000, 22,000) 3,000 (1,000, 14,000) 0.048
CEA (ng/mL) 17.90 (1.93, 215.23) 1.22 (0.73, 2.05) <0.001
LDH (U/L) 289 (167, 557) 230 (116, 575) 0.004
ADA (U/L) 10.9 (6.9, 14.7) 11.1 (7.3, 16.3) 0.409

Notes.

Data are expressed as the median and interquartile range (IQR).